bioAffinity Technologies (BIAFW) Change in Account Payables (2021 - 2026)
bioAffinity Technologies (BIAFW) reported Change in Account Payables of $74310.0 for Q1 2026, down 81.15% year-over-year from $394267.0 in Q1 2025, and up 141.55% quarter-over-quarter from -$178860.0 in Q4 2025.
bioAffinity Technologies (BIAFW) Change in Account Payables (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAFW) has 6 years of Change in Account Payables data on file, last reported at $74310.0 in Q1 2026.
- Change in Account Payables for Q1 2026 came in at $74310.0, down 81.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$545367.0 (down 154.67% YoY), and the FY2025 annual result was -$225410.0, down 158.93% from the prior year.
- Change in Account Payables advanced to $74310.0 in Q1 2026 per BIAFW's latest filing, from -$178860.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $577474.0 in Q3 2023 and troughed at -$435285.0 in Q3 2022.
- A 5-year average of $19503.2 and a median of $17284.0 in 2022 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2023 and 2024: Change in Account Payables plunged 1248.49% in 2023, then surged 1565.44% in 2024.
- A 5-year view of Change in Account Payables shows it stood at $195360.0 in 2022, then plunged by 315.67% to -$421337.0 in 2023, then jumped by 148.51% to $204373.0 in 2024, then plunged by 187.52% to -$178860.0 in 2025, then jumped by 141.55% to $74310.0 in 2026.
- Business Quant data shows BIAFW's Change in Account Payables at $74310.0 in Q1 2026, -$178860.0 in Q4 2025, and -$229076.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | - |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -41.00 Mn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 11.22 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 15.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | - |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 21.88 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -12.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -38.09 Mn |
| 10 | bioAffinity Technologies | - | - | - | 74,310.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74,310.00 |
| Mar 31, 2026 | 74,310.00 |
| Dec 31, 2025 | -178,860.00 |
| Dec 31, 2025 | -178,860.00 |
| Sep 30, 2025 | -229,076.00 |
| Sep 30, 2025 | -229,076.00 |
| Jun 30, 2025 | -211,741.00 |
| Jun 30, 2025 | -211,741.00 |
| Mar 31, 2025 | 394,267.00 |
| Mar 31, 2025 | 394,267.00 |
| Dec 31, 2024 | 204,373.00 |
| Dec 31, 2024 | 204,373.00 |
| Sep 30, 2024 | -65,165.00 |
| Sep 30, 2024 | -65,165.00 |
| Jun 30, 2024 | 464,109.00 |
| Jun 30, 2024 | 464,109.00 |
| Mar 31, 2024 | -220,796.00 |
| Mar 31, 2024 | -220,796.00 |
| Dec 31, 2023 | -421,337.00 |
| Dec 31, 2023 | -421,337.00 |